Please login to the form below

Not currently logged in
Email:
Password:

GPI appoints commercial director

Alan Stewart joins the life science management consultancy's executive team

GPI Alan StewartLondon, UK-based Global Pricing Innovations has strengthened its executive team with the appointment of Alan Stewart as commercial director.

Stewart joins the pharmaceutical and biotech pricing solutions firm from IMS Health, where he served as a global pricing solution specialist.

Prior to this, he was a senior business account manager at Aachen, Germany-headquartered Grünenthal, and held a series of sales, brand marketing and strategy positions at Eli Lilly and Bayer.

Preeti Patel, chief executive of GPI, said: “I am thrilled that Alan is joining our team. We view his appointment as a sign of our commitment to being a leading provider in the industry.

“Alan is a true sales professional and shares our values, focus on innovation, and places the same strong emphasis on the customer experience as we do.

“Alan's wealth of experience within the industry and impeccable reputation for providing high quality service makes him the perfect addition for the company.”

16th January 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics